AMIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Autonomix Medical Inc (AMIX) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock shows weak technical indicators, no positive trading signals, and a lack of significant catalysts. Additionally, the company's financial performance is poor, with negative earnings and no revenue growth. Analysts have lowered the price target due to expected share dilution, further reducing its attractiveness.
The technical indicators for AMIX are bearish. The MACD is below zero and negatively contracting, RSI is neutral at 48.558, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.376 and resistance at 0.41.
NULL identified. No recent news or significant trading trends from insiders or hedge funds.
Analysts have lowered the price target from $5 to $2 due to expected share dilution. The company's financials show no revenue growth and significant losses, with EPS dropping 75.34% YoY.
In Q3 2026, AMIX reported no revenue growth (0% YoY), a net loss of -$3.26M (up 20.24% YoY), and a significant EPS decline of -75.34% YoY. Gross margin remains at 0%.
Maxim maintains a Buy rating but has lowered the price target from $5 to $2 due to expected share dilution. Analysts acknowledge slightly better-than-expected Q3 results but remain cautious about the stock's future.
